ruxolitinib

C-C motif chemokine ligand 2 ; Homo sapiens







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33965175 Ruxolitinib Inhibits IFNγ Licensing of Human Bone Marrow Derived Mesenchymal Stromal Cells. 2021 May 1
2 29645296 Effects of JAK1/2 inhibition on bone marrow stromal cells of myeloproliferative neoplasm (MPN) patients and healthy individuals. 2018 Jul 1
3 29939445 The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release. 2018 Nov 1
4 23542035 IFNβ autocrine feedback is required to sustain TLR induced production of MCP-1 in macrophages. 2013 May 21 1